TCM
TDOC icon

Triumph Capital Management’s Teladoc Health TDOC Stock Holding History

Triumph Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,154
Closed -$413K – 258
2023
Q4 		$413K Buy
19,154
+1,956
+11% +$36.1K 0.18% 114
2023
Q3 		$320K Buy
+17,198
New +$401K 0.15% 146

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Triumph Capital Management's TDOC Position: Q1 2024 in Review

Triumph Capital Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 19,154 shares — an estimated $413K sold.

Triumph Capital Management first reported a position in TDOC in Q3 2023 and held it in 2 quarters. The position peaked at $413K in Q4 2023. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Triumph Capital Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Triumph Capital Management sold 19,154 Teladoc Health shares in Q1 2024, an estimated $413K.
  • Triumph Capital Management first reported a position in Teladoc Health in Q3 2023 and held it in 2 quarters.
  • Triumph Capital Management's Teladoc Health position peaked at $413K in Q4 2023.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Triumph Capital Management's 13F filing for Q1 2024, filed 25 Apr 2024.